Elmiron Lawsuit- Elmiron linked to Maculopathy

Elmiron lawsuit lawyers at Arentz Law are standing by ready to assist anyone who may have been negatively affected by taking Elmiron. Between 1996 and 2019 Janssen Pharmaceuticals, and parent company Johnson & Johnson have made millions on the sale of Elmiron. However, that has not helped patients who have used Elmiron. In 2019 at the American Academy of Ophthalmology Drs. Robin A. Vora, Amar P. Patel, and Ronald Melles presented research showing clear toxicity levels in patients taking Elmiron.

What is Elmiron?

Elmiron (pentosan polysulfate sodium) was approved for sale in 1996 under the Orphan Drug Act, or ODA. The ODA grants special status to companies that manufacture medications prescribed to treat rare diseases. Elmiron is a prescription medication used to treat bladder inflammation in people who suffer from interstitial cystitis (IC). IC is a chronic condition that causes bladder pain and inflammation. It is currently the only drug approved to treat IC, with no generic versions. According to HealthDay  Women more often use the drug long-term.  When initially introduced in 1996 Elmiron was thought to be completely safe. However, in 2019 it was discovered that the use of Elmiron can cause retinal damage to the eyes. This damage is called Maculopathy, a progressive disease that can lead to vision loss. Patients who suffer from Maculopathy risk losing central vision.

Maculopathy Connected to Elmiron

Maculopathy is a progressive disease connected to the use of Elmiron that usually affects both eyes. This disease affects the macula part of the eye, which is located in the back of the retina. The macula gives people the ability to read, see detail, and most importantly focus on central vision. People who suffer from central vision loss essential cant see what is right in front of them. If central vision loss becomes severe you could be classified as blind. Below are some of the symptoms connected to Maculopathy

• Blurry Spots in Center of vision
• Blank or dark spots in the center of vision
• Difficulty Reading
• Loss of clear color vision
• Objects Appear distorted
• Straight lines that appear crooked or wavy

Why File your Elmiron Lawsuit

When a patient is harmed by taking Elmiron, whether or not Janssen Pharmaceuticals knew about the side effect during their clinical trials, they need to be compensated.  Further, the company needs to warn the public of the potentially deadly side effect (in this case Maculopathy), in order to help prevent further instances of people being hurt. Invokana lawsuit will help two ways.  First, you can be compensated for medical expenses and other damages that you may have suffered by taking a drug and not being warned about this deadly side effect.  Second, your lawsuit will help to raise awareness of the dangers of this drug.  Many more people may be at risk, and your lawsuit will help prevent a major health catastrophe for them.

Filing Your Elmiron Lawsuit

Drug companies have a responsibility to warn their patients of all the potential side effects of a drug; no matter how rare those side effects are. If you have used Elmiron, and you have suffered from Maculopathy, you may be able to file an Elmiron lawsuit.  Your lawsuit will help you pay for medical expenses, and it will raise awareness that this drug is not safe to be used.  To get started call Arentz Law National Injury Lawyers at 1-800-305-6000, or fill out the contact form on this page.

Arentz Law has dangerous drug attorneys in Southern California.  These attorneys can handle cases from all 50 states.